- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the China Alpha Synuclein market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Alpha Synuclein market. Detailed analysis of key players, along with key growth strategies adopted by Alpha Synuclein industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Prothena Corp Plc
AFFiRiS AG
Genmab A/S
MedImmune LLC
BioArctic AB
AC Immune SA
Biogen Inc
Evotec AG
QR Pharma Inc
reMYND NV
H Lundbeck A/S
Neuropore Therapies Inc
ICB International Inc
nLife Therapeutics SL
By Type:
AV-1950R
AV-1947D
BAN-0805
BIIB-054
DPC-003
Others
By End-User:
Multiple System Atrophy
Neurodegenerative Disease
Lewy Body Dementia
Others
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Alpha Synuclein Market
-
1.3 Market Segment by Type
-
1.3.1 China Alpha Synuclein Market Size and Growth Rate of AV-1950R from 2016 to 2027
-
1.3.2 China Alpha Synuclein Market Size and Growth Rate of AV-1947D from 2016 to 2027
-
1.3.3 China Alpha Synuclein Market Size and Growth Rate of BAN-0805 from 2016 to 2027
-
1.3.4 China Alpha Synuclein Market Size and Growth Rate of BIIB-054 from 2016 to 2027
-
1.3.5 China Alpha Synuclein Market Size and Growth Rate of DPC-003 from 2016 to 2027
-
1.3.6 China Alpha Synuclein Market Size and Growth Rate of Others from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Alpha Synuclein Market Size and Growth Rate of Multiple System Atrophy from 2016 to 2027
-
1.4.2 China Alpha Synuclein Market Size and Growth Rate of Neurodegenerative Disease from 2016 to 2027
-
1.4.3 China Alpha Synuclein Market Size and Growth Rate of Lewy Body Dementia from 2016 to 2027
-
1.4.4 China Alpha Synuclein Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Alpha Synuclein Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Alpha Synuclein Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Alpha Synuclein Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Alpha Synuclein Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Alpha Synuclein Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Alpha Synuclein Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Alpha Synuclein Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Alpha Synuclein Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Alpha Synuclein by Major Types
-
3.4.1 Market Size and Growth Rate of AV-1950R
-
3.4.2 Market Size and Growth Rate of AV-1947D
-
3.4.3 Market Size and Growth Rate of BAN-0805
-
3.4.4 Market Size and Growth Rate of BIIB-054
-
3.4.5 Market Size and Growth Rate of DPC-003
-
3.4.6 Market Size and Growth Rate of Others
4 Segmentation of Alpha Synuclein Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Alpha Synuclein by Major End-Users
-
4.4.1 Market Size and Growth Rate of Alpha Synuclein in Multiple System Atrophy
-
4.4.2 Market Size and Growth Rate of Alpha Synuclein in Neurodegenerative Disease
-
4.4.3 Market Size and Growth Rate of Alpha Synuclein in Lewy Body Dementia
-
4.4.4 Market Size and Growth Rate of Alpha Synuclein in Others
5 Market Analysis by Regions
-
5.1 China Alpha Synuclein Production Analysis by Regions
-
5.2 China Alpha Synuclein Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Alpha Synuclein Landscape Analysis
-
6.1 North China Alpha Synuclein Landscape Analysis by Major Types
-
6.2 North China Alpha Synuclein Landscape Analysis by Major End-Users
7 Central China Alpha Synuclein Landscape Analysis
-
7.1 Central China Alpha Synuclein Landscape Analysis by Major Types
-
7.2 Central China Alpha Synuclein Landscape Analysis by Major End-Users
8 South China Alpha Synuclein Landscape Analysis
-
8.1 South China Alpha Synuclein Landscape Analysis by Major Types
-
8.2 South China Alpha Synuclein Landscape Analysis by Major End-Users
9 East China Alpha Synuclein Landscape Analysis
-
9.1 East China Alpha Synuclein Landscape Analysis by Major Types
-
9.2 East China Alpha Synuclein Landscape Analysis by Major End-Users
10 Northeast China Alpha Synuclein Landscape Analysis
-
10.1 Northeast China Alpha Synuclein Landscape Analysis by Major Types
-
10.2 Northeast China Alpha Synuclein Landscape Analysis by Major End-Users
11 Southwest China Alpha Synuclein Landscape Analysis
-
11.1 Southwest China Alpha Synuclein Landscape Analysis by Major Types
-
11.2 Southwest China Alpha Synuclein Landscape Analysis by Major End-Users
12 Northwest China Alpha Synuclein Landscape Analysis
-
12.1 Northwest China Alpha Synuclein Landscape Analysis by Major Types
-
12.2 Northwest China Alpha Synuclein Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Prothena Corp Plc
-
13.1.1 Prothena Corp Plc Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 AFFiRiS AG
-
13.2.1 AFFiRiS AG Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Genmab A/S
-
13.3.1 Genmab A/S Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 MedImmune LLC
-
13.4.1 MedImmune LLC Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 BioArctic AB
-
13.5.1 BioArctic AB Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 AC Immune SA
-
13.6.1 AC Immune SA Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Biogen Inc
-
13.7.1 Biogen Inc Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Evotec AG
-
13.8.1 Evotec AG Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 QR Pharma Inc
-
13.9.1 QR Pharma Inc Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 reMYND NV
-
13.10.1 reMYND NV Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
-
13.11 H Lundbeck A/S
-
13.11.1 H Lundbeck A/S Company Profile and Recent Development
-
13.11.2 Market Performance
-
13.11.3 Product and Service Introduction
-
13.12 Neuropore Therapies Inc
-
13.12.1 Neuropore Therapies Inc Company Profile and Recent Development
-
13.12.2 Market Performance
-
13.12.3 Product and Service Introduction
-
13.13 ICB International Inc
-
13.13.1 ICB International Inc Company Profile and Recent Development
-
13.13.2 Market Performance
-
13.13.3 Product and Service Introduction
-
13.14 nLife Therapeutics SL
-
13.14.1 nLife Therapeutics SL Company Profile and Recent Development
-
13.14.2 Market Performance
-
13.14.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Alpha Synuclein Market Size and Growth Rate of AV-1950R from 2016 to 2027
-
Figure China Alpha Synuclein Market Size and Growth Rate of AV-1947D from 2016 to 2027
-
Figure China Alpha Synuclein Market Size and Growth Rate of BAN-0805 from 2016 to 2027
-
Figure China Alpha Synuclein Market Size and Growth Rate of BIIB-054 from 2016 to 2027
-
Figure China Alpha Synuclein Market Size and Growth Rate of DPC-003 from 2016 to 2027
-
Figure China Alpha Synuclein Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Alpha Synuclein Market Size and Growth Rate of Multiple System Atrophy from 2016 to 2027
-
Figure China Alpha Synuclein Market Size and Growth Rate of Neurodegenerative Disease from 2016 to 2027
-
Figure China Alpha Synuclein Market Size and Growth Rate of Lewy Body Dementia from 2016 to 2027
-
Figure China Alpha Synuclein Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Alpha Synuclein Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Alpha Synuclein Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Alpha Synuclein Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Alpha Synuclein Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Alpha Synuclein Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Alpha Synuclein Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Alpha Synuclein Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Alpha Synuclein Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Alpha Synuclein
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Alpha Synuclein by Different Types from 2016 to 2027
-
Table Consumption Share of Alpha Synuclein by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of AV-1950R
-
Figure Market Size and Growth Rate of AV-1947D
-
Figure Market Size and Growth Rate of BAN-0805
-
Figure Market Size and Growth Rate of BIIB-054
-
Figure Market Size and Growth Rate of DPC-003
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Alpha Synuclein by Different End-Users from 2016 to 2027
-
Table Consumption Share of Alpha Synuclein by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Multiple System Atrophy
-
Figure Market Size and Growth Rate of Neurodegenerative Disease
-
Figure Market Size and Growth Rate of Lewy Body Dementia
-
Figure Market Size and Growth Rate of Others
-
Table China Alpha Synuclein Production by Regions
-
Table China Alpha Synuclein Production Share by Regions
-
Figure China Alpha Synuclein Production Share by Regions in 2016
-
Figure China Alpha Synuclein Production Share by Regions in 2021
-
Figure China Alpha Synuclein Production Share by Regions in 2027
-
Table China Alpha Synuclein Consumption by Regions
-
Table China Alpha Synuclein Consumption Share by Regions
-
Figure China Alpha Synuclein Consumption Share by Regions in 2016
-
Figure China Alpha Synuclein Consumption Share by Regions in 2021
-
Figure China Alpha Synuclein Consumption Share by Regions in 2027
-
Table North China Alpha Synuclein Consumption by Types from 2016 to 2027
-
Table North China Alpha Synuclein Consumption Share by Types from 2016 to 2027
-
Figure North China Alpha Synuclein Consumption Share by Types in 2016
-
Figure North China Alpha Synuclein Consumption Share by Types in 2021
-
Figure North China Alpha Synuclein Consumption Share by Types in 2027
-
Table North China Alpha Synuclein Consumption by End-Users from 2016 to 2027
-
Table North China Alpha Synuclein Consumption Share by End-Users from 2016 to 2027
-
Figure North China Alpha Synuclein Consumption Share by End-Users in 2016
-
Figure North China Alpha Synuclein Consumption Share by End-Users in 2021
-
Figure North China Alpha Synuclein Consumption Share by End-Users in 2027
-
Table Central China Alpha Synuclein Consumption by Types from 2016 to 2027
-
Table Central China Alpha Synuclein Consumption Share by Types from 2016 to 2027
-
Figure Central China Alpha Synuclein Consumption Share by Types in 2016
-
Figure Central China Alpha Synuclein Consumption Share by Types in 2021
-
Figure Central China Alpha Synuclein Consumption Share by Types in 2027
-
Table Central China Alpha Synuclein Consumption by End-Users from 2016 to 2027
-
Table Central China Alpha Synuclein Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Alpha Synuclein Consumption Share by End-Users in 2016
-
Figure Central China Alpha Synuclein Consumption Share by End-Users in 2021
-
Figure Central China Alpha Synuclein Consumption Share by End-Users in 2027
-
Table South China Alpha Synuclein Consumption by Types from 2016 to 2027
-
Table South China Alpha Synuclein Consumption Share by Types from 2016 to 2027
-
Figure South China Alpha Synuclein Consumption Share by Types in 2016
-
Figure South China Alpha Synuclein Consumption Share by Types in 2021
-
Figure South China Alpha Synuclein Consumption Share by Types in 2027
-
Table South China Alpha Synuclein Consumption by End-Users from 2016 to 2027
-
Table South China Alpha Synuclein Consumption Share by End-Users from 2016 to 2027
-
Figure South China Alpha Synuclein Consumption Share by End-Users in 2016
-
Figure South China Alpha Synuclein Consumption Share by End-Users in 2021
-
Figure South China Alpha Synuclein Consumption Share by End-Users in 2027
-
Table East China Alpha Synuclein Consumption by Types from 2016 to 2027
-
Table East China Alpha Synuclein Consumption Share by Types from 2016 to 2027
-
Figure East China Alpha Synuclein Consumption Share by Types in 2016
-
Figure East China Alpha Synuclein Consumption Share by Types in 2021
-
Figure East China Alpha Synuclein Consumption Share by Types in 2027
-
Table East China Alpha Synuclein Consumption by End-Users from 2016 to 2027
-
Table East China Alpha Synuclein Consumption Share by End-Users from 2016 to 2027
-
Figure East China Alpha Synuclein Consumption Share by End-Users in 2016
-
Figure East China Alpha Synuclein Consumption Share by End-Users in 2021
-
Figure East China Alpha Synuclein Consumption Share by End-Users in 2027
-
Table Northeast China Alpha Synuclein Consumption by Types from 2016 to 2027
-
Table Northeast China Alpha Synuclein Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Alpha Synuclein Consumption Share by Types in 2016
-
Figure Northeast China Alpha Synuclein Consumption Share by Types in 2021
-
Figure Northeast China Alpha Synuclein Consumption Share by Types in 2027
-
Table Northeast China Alpha Synuclein Consumption by End-Users from 2016 to 2027
-
Table Northeast China Alpha Synuclein Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Alpha Synuclein Consumption Share by End-Users in 2016
-
Figure Northeast China Alpha Synuclein Consumption Share by End-Users in 2021
-
Figure Northeast China Alpha Synuclein Consumption Share by End-Users in 2027
-
Table Southwest China Alpha Synuclein Consumption by Types from 2016 to 2027
-
Table Southwest China Alpha Synuclein Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Alpha Synuclein Consumption Share by Types in 2016
-
Figure Southwest China Alpha Synuclein Consumption Share by Types in 2021
-
Figure Southwest China Alpha Synuclein Consumption Share by Types in 2027
-
Table Southwest China Alpha Synuclein Consumption by End-Users from 2016 to 2027
-
Table Southwest China Alpha Synuclein Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Alpha Synuclein Consumption Share by End-Users in 2016
-
Figure Southwest China Alpha Synuclein Consumption Share by End-Users in 2021
-
Figure Southwest China Alpha Synuclein Consumption Share by End-Users in 2027
-
Table Northwest China Alpha Synuclein Consumption by Types from 2016 to 2027
-
Table Northwest China Alpha Synuclein Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Alpha Synuclein Consumption Share by Types in 2016
-
Figure Northwest China Alpha Synuclein Consumption Share by Types in 2021
-
Figure Northwest China Alpha Synuclein Consumption Share by Types in 2027
-
Table Northwest China Alpha Synuclein Consumption by End-Users from 2016 to 2027
-
Table Northwest China Alpha Synuclein Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Alpha Synuclein Consumption Share by End-Users in 2016
-
Figure Northwest China Alpha Synuclein Consumption Share by End-Users in 2021
-
Figure Northwest China Alpha Synuclein Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Prothena Corp Plc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Prothena Corp Plc
-
Figure Sales and Growth Rate Analysis of Prothena Corp Plc
-
Figure Revenue and Market Share Analysis of Prothena Corp Plc
-
Table Product and Service Introduction of Prothena Corp Plc
-
Table Company Profile and Development Status of AFFiRiS AG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AFFiRiS AG
-
Figure Sales and Growth Rate Analysis of AFFiRiS AG
-
Figure Revenue and Market Share Analysis of AFFiRiS AG
-
Table Product and Service Introduction of AFFiRiS AG
-
Table Company Profile and Development Status of Genmab A/S
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genmab A/S
-
Figure Sales and Growth Rate Analysis of Genmab A/S
-
Figure Revenue and Market Share Analysis of Genmab A/S
-
Table Product and Service Introduction of Genmab A/S
-
Table Company Profile and Development Status of MedImmune LLC
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of MedImmune LLC
-
Figure Sales and Growth Rate Analysis of MedImmune LLC
-
Figure Revenue and Market Share Analysis of MedImmune LLC
-
Table Product and Service Introduction of MedImmune LLC
-
Table Company Profile and Development Status of BioArctic AB
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioArctic AB
-
Figure Sales and Growth Rate Analysis of BioArctic AB
-
Figure Revenue and Market Share Analysis of BioArctic AB
-
Table Product and Service Introduction of BioArctic AB
-
Table Company Profile and Development Status of AC Immune SA
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AC Immune SA
-
Figure Sales and Growth Rate Analysis of AC Immune SA
-
Figure Revenue and Market Share Analysis of AC Immune SA
-
Table Product and Service Introduction of AC Immune SA
-
Table Company Profile and Development Status of Biogen Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogen Inc
-
Figure Sales and Growth Rate Analysis of Biogen Inc
-
Figure Revenue and Market Share Analysis of Biogen Inc
-
Table Product and Service Introduction of Biogen Inc
-
Table Company Profile and Development Status of Evotec AG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Evotec AG
-
Figure Sales and Growth Rate Analysis of Evotec AG
-
Figure Revenue and Market Share Analysis of Evotec AG
-
Table Product and Service Introduction of Evotec AG
-
Table Company Profile and Development Status of QR Pharma Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of QR Pharma Inc
-
Figure Sales and Growth Rate Analysis of QR Pharma Inc
-
Figure Revenue and Market Share Analysis of QR Pharma Inc
-
Table Product and Service Introduction of QR Pharma Inc
-
Table Company Profile and Development Status of reMYND NV
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of reMYND NV
-
Figure Sales and Growth Rate Analysis of reMYND NV
-
Figure Revenue and Market Share Analysis of reMYND NV
-
Table Product and Service Introduction of reMYND NV
-
Table Company Profile and Development Status of H Lundbeck A/S
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of H Lundbeck A/S
-
Figure Sales and Growth Rate Analysis of H Lundbeck A/S
-
Figure Revenue and Market Share Analysis of H Lundbeck A/S
-
Table Product and Service Introduction of H Lundbeck A/S
-
Table Company Profile and Development Status of Neuropore Therapies Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Neuropore Therapies Inc
-
Figure Sales and Growth Rate Analysis of Neuropore Therapies Inc
-
Figure Revenue and Market Share Analysis of Neuropore Therapies Inc
-
Table Product and Service Introduction of Neuropore Therapies Inc
-
Table Company Profile and Development Status of ICB International Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of ICB International Inc
-
Figure Sales and Growth Rate Analysis of ICB International Inc
-
Figure Revenue and Market Share Analysis of ICB International Inc
-
Table Product and Service Introduction of ICB International Inc
-
Table Company Profile and Development Status of nLife Therapeutics SL
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of nLife Therapeutics SL
-
Figure Sales and Growth Rate Analysis of nLife Therapeutics SL
-
Figure Revenue and Market Share Analysis of nLife Therapeutics SL
-
Table Product and Service Introduction of nLife Therapeutics SL
-